Found 0 matching trials
A Study to Determine if New Types of Malaria Vaccines Are Safe, Effective and Lead to Immunity in Kenyan Adults
PHASE2This is a phase IIb clinical trial in malaria-exposed individuals to assess...
Location
KEMRI/Wellcome Trust Programme, Centre for Geographic Medicine Research - Coast
A Safety, Immunogenicity and Efficacy Study of PvRII/Matrix-M in Healthy Thai Adults Living in Thailand ( MIST3 )
PHASE2This project is the third part of a 5-year research program entitled "Malar...
Location
Faculty of Tropical Medicine
R21/Matrix-M in African Children Against Clinical Malaria
PHASE3A Phase III randomized controlled multi-centre trial to evaluate the effica...
Status
Active Not Recruiting
Location
CCVTM, University of Oxford, Churchill Hospital
Dose Finding Trial of R21/Matrix-M in School Children
PHASE2This trial is a double-blind, randomised, trial recruiting participants fro...
Status
Active Not Recruiting
Location
Unité de Recherche Clinique de Nanoro (URCN)
Evaluation of the Safety and Immunogenicity of a Recombinant Trivalent Nanoparticle Influenza Vaccine With Matrix M-1 Adjuvant (NanoFlu)
PHASE1This was a Phase 1/2, randomized, observer-blinded, active-controlled trial...
Location
Research Site US108
Assessing Vaccine Effectiveness of R21/Matrix-M Across Malaria Transmission Settings (AVERT)
N/AThe AVERT study is a prospective observational test-negative case control s...
Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant
PHASE12019nCoV-101 is a 2-part, randomized, observer-blinded, placebo-controlled,...
Location
Meridian Clinical Research-(Savannah Georgia) - Platinum - PPDS - Phase 2
Assessment of Safety, Immunogenicity and Efficacy of R21/Matrix-M1 Malaria Vaccine in Healthy WOCBP in Mali
PHASE2This will be a double-blind, individually randomised trial, to assess the s...
Status
Active Not Recruiting
Location
Koumantou Study Clinic
Evaluation of the Safety and Immunogenicity of SII Vaccine Constructs Based on the SARS-CoV-2 (COVID-19) Variant in Adults
PHASE1This is a randomized, observer-blinded, Phase 1/2 study with an open-label ...
Location
Australian Clinical Research Network (ACRN)
A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, Administered With and Without Matrix-M1
PHASE1This is a clinical trial in which healthy volunteers will be administered o...
Location
Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital